KRAS and neoplasm: Interestingly, KEAP1/STK11 co-mutations occurred more frequently than KRAS/KEAP1 or KRAS/STK11 co-mutations, suggesting a functional synergy between NRF2- and LKB1-regulated pathways in tumor progression.